In a regulatory filing, RxSight disclosed that its director Juliet Tammenoms Bakker bought 480K shares of common stock on February 10th in a total transaction size of $6.0M.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RXST:
- RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock
- RxSight 4M share Spot Secondary priced at $12.50
- RxSight, Inc. Announces Pricing of Public Offering of Common Stock
- RxSight announces $40M common stock offering
- RxSight reports preliminary Q4 revenue $16.1M, consensus $14.63M
